Skip to content

MBX Biosciences, Inc. MBX Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$75.23M-5.0%$79.16M+6.1%$74.62M+3.5%$72.1M+4.8%$68.77M+19.8%
$23.56M+24.7%$18.9M+16.3%$16.25M+12.4%$14.46M+14.4%$12.64M+17.2%
$98.79M+0.8%$98.06M+7.9%$90.87M+5.0%$86.56M+6.3%$81.41M+19.4%
-$98.79M-0.8%-$98.06M-7.9%-$90.87M-5.0%-$86.56M-6.3%-$81.41M-19.4%
-$86.64M+0.4%-$87M-8.1%-$80.5M-4.5%-$77.02M-4.8%-$73.47M-18.6%
-$2.16+8.9%-$2.37
-$98.47M-0.8%-$97.72M-7.9%-$90.54M-5.0%-$86.22M-6.3%-$81.07M-19.4%
-$98.79M-0.8%-$98.06M-7.9%-$90.87M-5.0%-$86.56M-6.3%-$81.41M-19.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does MBX Biosciences, Inc.'s income statement data come from?
Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.